There are believed to be around 1.5 million different species of fungus on Earth, but one mold, known as Aspergillus fumigatus, causes the majority of cases of invasive aspergillosis—a devastating illness that kills 90 percent of patients with weakened immune systems or lung diseases.
Until now researchers could not explain the virulence of this particular fungus, but a recent discovery explains why this organism is more dangerous than its relatives. The results of the study, which appears in PLOS Pathogens, may change the way patients are treated for invasive aspergillosis.
A. fumigatus lives both indoors and outdoors and most people breathe in its spores every day without getting sick. However, people with weakened immune systems or lung diseases are at higher risk of developing health problems from this fungus. The types of health problems caused by A. fumigatus include allergic reactions, lung infections, and infections in other organs.
“We found that A. fumigatus was developing a sugar armor that protects it from being killed by our white blood cells, called neutrophils, that usually fight diseases,” explains Donald Sheppard, director of the Division of Infectious Diseases at the McGill University Health Centre and a professor in the departments of medicine and microbiology and immunology at McGill University.
“This is an important discovery because we did not know why A. fumigatus was so virulent in some patients, and now we are starting to develop drugs against this sugar-coating.”
Sheppard’s team set out to explore features that could facilitate infection by A. fumigatus as compared with less pathogenic Aspergillus species. Because they had previously identified a particular sugar in the cell wall of A. fumigatus called GAG (galactosaminogalactan) as critical to the fungus’ ability to outwit the host immune system, the researchers started by testing whether differences in GAG production contribute to differences in the fungus’s ability to cause disease. By manipulating A.fumigatus to make it synthesize more GAG, they made it more virulent.
“We also observed that A. fumigatus, due to this sugar-coating, was able to escape traps produced by neutrophils,” explains Sheppard. Neutrophils respond to an infection by developing a web-like network called Neutrophils Extracellular Traps (NETs), composed of DNA and proteins. The NETs are designed to trap and kill invading pathogens, but the sugar-coating protects A. fumigatus.
“Indeed, the sugar-coat repels the NETS and prevents them from binding because both the peptides in the NETs and GAG are positively charged, thus repelling each other. Now that we have highlighted the importance of GAG as a key factor for the ability of A. fumigatus to develop acute lung infection, targeting this sugar armour may be an effective antifungal approach in some patients,” concludes Sheppard.
The Canadian Cystic Fibrosis Foundation, the Canadian Institutes of Health Research, and the US National Institutes of Health supported the work. Researchers also received individual support from Fonds de recherche du Québec – Santé and the Research Institute of the McGill University Health Centre.
Source: McGill University